État de l’art et perspectives d’avenir des biopsies cérébrales pour les maladies neurologiques oncologiques et cryptogéniques

Bulletin de l'Académie Nationale de Médecine - Tập 207 - Trang 1100-1110 - 2023
Bertrand Mathon1,2,3,4
1Sorbonne University, Department of Neurosurgery, AP–HP, La Pitié-Salpêtrière Hospital, 75013 Paris, France
2Sorbonne University, GRC 23, Brain Machine Interface, AP–HP, Paris, France
3Sorbonne University, GRC 33, Robotics and Surgical Innovation, AP–HP, Paris, France
4Paris Brain Institute, ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne University, UMRS, 1127 Paris, France

Tài liệu tham khảo

Chabaane, 2020, Efficacy of a second brain biopsy for intracranial lesions after initial negativity, J Clin Neurol, 16, 659, 10.3988/jcn.2020.16.4.659 Riche, 2021, Complications after frame-based stereotactic brain biopsy: a systematic review, Neurosurg Rev, 44, 301, 10.1007/s10143-019-01234-w Riche, 2022, Severity, timeline, and management of complications after stereotactic brain biopsy, J Neurosurg, 136, 867, 10.3171/2021.3.JNS21134 Bex, 2022, Advances technological innovations, and future prospects in stereotactic brain biopsies, Neurosurg Rev, 46, 5, 10.1007/s10143-022-01918-w Mathon, 2022, Outpatient stereotactic brain biopsies, Neurosurg Rev, 45, 661, 10.1007/s10143-021-01593-3 Mathon, 2019, Increasing the diagnostic yield of stereotactic brain biopsy using intraoperative histological smear, Clin Neurol Neurosurg, 186, 105544, 10.1016/j.clineuro.2019.105544 Hall, 1998, The safety and efficacy of stereotactic biopsy for intracranial lesions, Cancer, 82, 1749, 10.1002/(SICI)1097-0142(19980501)82:9<1756::AID-CNCR23>3.0.CO;2-2 Kim, 2003, Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment, Acta Neurochir (Wien), 145, 547, 10.1007/s00701-003-0048-8 Delattre, 2017, Improving diagnosis and management of primary brain tumors, Curr Opin Neurol, 30, 639, 10.1097/WCO.0000000000000500 Schuette, 2010, Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion, Neurology, 75, 419, 10.1212/WNL.0b013e3181eb5889 Noronha, 2019, Brain biopsy in suspected non-neoplastic neurological disease, Acta Neurochir (Wien), 161, 1139, 10.1007/s00701-019-03910-8 Layard Horsfall, 2020, The utility of brain biopsy in pediatric cryptogenic neurological disease, J Neurosurg Pediatr, 1 Mathon, 2021, Encephalitis of unknown etiology? Not until the results of a brain biopsy!, Clin Infect Dis, 10.1093/cid/ciaa1093 Mathon, 2020, Neurological diseases of unknown etiology: brain-biopsy diagnostic yields and safety, Eur J Intern Med, 80, 78, 10.1016/j.ejim.2020.05.029 Mathon, 2020, Letter to the Editor. Brain biopsy in children and adults with neurological diseases of unknown etiology: two sides of the same coin?, J Neurosurg Pediatr, 1 Pasternak, 2021, Evaluation of 311 contemporary cases of stereotactic biopsies in patients with neoplastic and non-neoplastic lesions-diagnostic yield and management of non-diagnostic cases, Neurosurg Rev Torres, 2016, Diagnostic yield and safety of brain biopsy for suspected primary central nervous system angiitis, Stroke, 47, 2127, 10.1161/STROKEAHA.116.013874 Vitelli, 2021, A diagnosis can hide another: the value of brain biopsy in neurological lesion of HIV patients, J Acquir Immune Defic Syndr, 86, e6, 10.1097/QAI.0000000000002511 Bai, 2015, Diagnostic value and safety of brain biopsy in patients with cryptogenic neurological disease: a systematic review and meta-analysis of 831 cases, Neurosurgery, 77, 283, 10.1227/NEU.0000000000000756 Santos, 2022, Impact of brain biopsy on management of nonneoplastic brain disease, Brain Spine, 2, 100863, 10.1016/j.bas.2022.100863 Mathon, 2022, Brain biopsy for neurological diseases of unknown etiology in critically ill patients: feasibility, safety, and diagnostic yield, Crit Care Med, 50, e516, 10.1097/CCM.0000000000005439 Pineton De Chambrun, 2022, Safety and diagnostic yield of brain biopsy in critically-ill patients, Med Intensive Reanim, 32 Salzberg, 2016, Next-generation sequencing in neuropathologic diagnosis of infections of the nervous system, Neurol Neuroimmunol Neuroinflamm, 3, e251, 10.1212/NXI.0000000000000251 Brown, 2018, Encephalitis diagnosis using metagenomics: application of next generation sequencing for undiagnosed cases, J Infect, 76, 225, 10.1016/j.jinf.2017.12.014 Pérot, 2021, Identification of umbre orthobunyavirus as a novel zoonotic virus responsible for lethal encephalitis in 2 French patients with hypogammaglobulinemia, Clin Infect Dis, 10.1093/cid/ciaa308 Rodriguez, 2020, Fatal measles inclusion-body encephalitis in adult with untreated AIDS, France, Emerging Infect Dis, 26, 2231, 10.3201/eid2609.200366 Valyraki, 2022, Human pegivirus identified in severe myelitis and optic neuritis in immunocompromised patients: a pathogenic role for a forgotten virus?, Rev Neurol (Paris) Dammers, 2008, Safety and efficacy of frameless and frame-based intracranial biopsy techniques, Acta Neurochir (Wien), 150, 23, 10.1007/s00701-007-1473-x Yamada, 2004, Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell's system, J Clin Neurosci, 11, 263, 10.1016/j.jocn.2003.03.004 Malaizé, 2022, Roles and outcomes of stereotactic biopsy for adult patients with brainstem lesion, J Neurooncol, 10.1007/s11060-022-04129-x Mathon, 2021, Stereotactic biopsies of brainstem lesions: dilemma on the best trajectory, Acta Neurochir (Wien) Mathon, 2021, Letter to the editor regarding “hemorrhagic attitude in frameless and frame-based stereotactic biopsy for deep-seated primary central nervous system lymphomas in immunocompetent patients: a multicentric analysis of the last twenty years”, World Neurosurg, 152, 242, 10.1016/j.wneu.2021.04.029 Mathon, 2021, The place of brain biopsy in patients with presumed relapse of CNS systemic lymphoma, J Neurosurg, 136, 933, 10.3171/2021.7.JNS211699 Houillier, 2020, Management and outcome of primary CNS lymphoma in the modern era: an LOC network study, Neurology, 94, e1027, 10.1212/WNL.0000000000008900 Hamisch, 2019, Frame-based stereotactic biopsy of deep-seated and midline structures in 511 procedures: feasibility, risk profile, and diagnostic yield, Acta Neurochir (Wien), 161, 2065, 10.1007/s00701-019-04020-1 Zrinzo, 2012, Pitfalls in precision stereotactic surgery, Surg Neurol Int, 3, S53, 10.4103/2152-7806.91612 Colbassani, 1988, CT-assisted stereotactic brain biopsy: value of intraoperative frozen section diagnosis, J Neurol Neurosurg Psychiatry, 51, 332, 10.1136/jnnp.51.3.332 Livermore, 2014, Yield and complications of frame-based and frameless stereotactic brain biopsy--the value of intra-operative histological analysis, Br J Neurosurg, 28, 637, 10.3109/02688697.2014.887657 Furtak, 2021, Infratentorial stereotactic biopsy of brainstem and cerebellar lesions, Brain Sci, 11, 1432, 10.3390/brainsci11111432 Neidert, 2022, Stimulated Raman histology in the neurosurgical workflow of a major European neurosurgical center – part A, Neurosurg Rev, 45, 1731, 10.1007/s10143-021-01712-0 Straehle, 2022, Neuropathological interpretation of stimulated Raman histology images of brain and spine tumors: part B, Neurosurg Rev, 45, 1721, 10.1007/s10143-021-01711-1 Hollon, 2020, Near real-time intraoperative brain tumor diagnosis using stimulated Raman histology and deep neural networks, Nat Med, 26, 52, 10.1038/s41591-019-0715-9 Reinecke, 2022, Novel rapid intraoperative qualitative tumor detection by a residual convolutional neural network using label-free stimulated Raman scattering microscopy, Acta Neuropathol Commun, 10, 109, 10.1186/s40478-022-01411-x Widhalm, 2012, Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies, Neurosurg Rev, 35, 381, 10.1007/s10143-012-0374-5 Millesi, 2020, Is intraoperative pathology needed if 5-aminolevulinic-acid-induced tissue fluorescence is found in stereotactic brain tumor biopsy?, Neurosurgery, 86, 366, 10.1093/neuros/nyz086 Singh, 2021, Fluorescein sodium fluorescence: role in stereotactic brain biopsy, Br J Neurosurg, 1 Xu, 2022, Correlation of tumor pathology with fluorescein uptake and MRI contrast-enhancement in stereotactic biopsies, J Clin Med, 11, 3330, 10.3390/jcm11123330 Thien, 2018, Investigation of the usefulness of fluorescein sodium fluorescence in stereotactic brain biopsy, Acta Neurochir (Wien), 160, 317, 10.1007/s00701-017-3429-0 Thien, 2017, The Fluoropen: a simple low-cost device to detect intraoperative fluorescein fluorescence in stereotactic needle biopsy of brain tumors, Acta Neurochir (Wien), 159, 371, 10.1007/s00701-016-3041-8 Rey-Dios, 2014, Use of intraoperative fluorescein sodium fluorescence to improve the accuracy of tissue diagnosis during stereotactic needle biopsy of high-grade gliomas, Acta Neurochir (Wien), 156, 1071, 10.1007/s00701-014-2097-6 Catapano, 2019, Fluorescein-assisted stereotactic needle biopsy of brain tumors: a single-center experience and systematic review, Neurosurg Rev, 42, 309, 10.1007/s10143-018-0947-z Mohyeldin, 2017, Stereotactic biopsy platforms with intraoperative imaging guidance, Neurosurg Clin N Am, 28, 465, 10.1016/j.nec.2017.05.002 Ikeda, 2022, Frameless stereotactic biopsy with intraoperative computed tomography “assessment of efficacy and real target registration error”, Neurol Med Chir (Tokyo), 62, 195, 10.2176/jns-nmc.2021-0343 Göbel, 2012, Optical needle endoscope for safe and precise stereotactically guided biopsy sampling in neurosurgery, Opt Express, 20, 26117, 10.1364/OE.20.026117 Richter, 2021, Optical brain biopsy with a fluorescence and vessel tracing probe, Oper Neurosurg (Hagerstown), 21, 217, 10.1093/ons/opab216 Akshulakov, 2019, Current trends for improving safety of stereotactic brain biopsies: advanced optical methods for vessel avoidance and tumor detection, Front Oncol, 9, 10.3389/fonc.2019.00947 Haj-Hosseini, 2018, 5-ALA fluorescence and laser Doppler flowmetry for guidance in a stereotactic brain tumor biopsy, Biomed Opt Express, 9, 2284, 10.1364/BOE.9.002284 Kut, 2015, Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography, Sci Transl Med, 7, 10.1126/scitranslmed.3010611 Ramakonar, 2018, Intraoperative detection of blood vessels with an imaging needle during neurosurgery in humans, Sci Adv, 4, 10.1126/sciadv.aav4992 Pichette, 2015, Sensitivity analysis aimed at blood vessels detection using interstitial optical tomography during brain needle biopsy procedures, Biomed Opt Express, 6, 4238, 10.1364/BOE.6.004238 Gibby, 2021, The application of augmented reality-based navigation for accurate target acquisition of deep brain sites: advances in neurosurgical guidance, J Neurosurg, 1 Chan, 2022, Measurement of aspiration pressure in cannula brain tumour biopsy and its correlation with ultrasonographic elastography, J Clin Neurosci, 103, 9, 10.1016/j.jocn.2022.06.014 Mallereau, 2022, Pushing the boundaries of accuracy and reliability during stereotactic procedures: a prospective study on 526 biopsies comparing the frameless robotic and Image-Guided Surgery systems, J Clin Neurosci, 95, 203, 10.1016/j.jocn.2021.11.034 Hu, 2022, A comparation between frame-based and robot-assisted in stereotactic biopsy, Front Neurol, 13, 928070, 10.3389/fneur.2022.928070 Ha, 2021, High precision bone cutting by Er: YAG lasers might minimize the invasiveness of navigated brain biopsies, Front Oncol, 11, 690374, 10.3389/fonc.2021.690374 Giannakou, 2019, MRI-guided frameless biopsy robotic system with the inclusion of unfocused ultrasound transducer for brain cancer ablation, Int J Med Robot, 15, e1951, 10.1002/rcs.1951 Touat, 2020, Mechanisms and therapeutic implications of hypermutation in gliomas, Nature, 580, 517, 10.1038/s41586-020-2209-9 Hernández-Verdin, 2023, Molecular and clinical diversity in primary central nervous system lymphoma, Ann Oncol, 34, 186, 10.1016/j.annonc.2022.11.002 Di Stefano, 2020, Clinical, molecular, and radiomic profile of gliomas with FGFR3-TACC3 fusions, Neuro Oncol, 22, 1614, 10.1093/neuonc/noaa121